Skip to main content
Clinical Trials/NCT04146558
NCT04146558
Completed
Phase 3

A Randomized Open Label Clinical Trial on the Efficacy of an Ayurvedic Treatment Package on Symptom Severity and Quality of Life in Plaque Psoriasis

Universität Duisburg-Essen1 site in 1 country90 target enrollmentDecember 4, 2019

Overview

Phase
Phase 3
Intervention
Individualized internal ayurvedic treatment
Conditions
Psoriasis
Sponsor
Universität Duisburg-Essen
Enrollment
90
Locations
1
Primary Endpoint
Psoriasis-specific quality of life
Status
Completed
Last Updated
10 months ago

Overview

Brief Summary

Psoriasis is a chronic, immune-mediated inflammatory skin disease that is associated with substantial impairment of physical and psychological quality of life. The conventional treatment protocols manages the condition but with remissions and relapses which create anxiety in patients. Many of the patients withdraw from active social life as the disease attains chronicity. Several studies are pointing towards a conjoint management strategy incorporating the traditional and alternate medical systems. In this regard, Ayurveda is commonly used by psoriatic patients in India. Considering this fact it is high time to conduct a study to scientifically evaluate the efficacy of Ayurvedic treatment protocol in managing psoriasis as well as its potential to improve the quality of life.

Registry
clinicaltrials.gov
Start Date
December 4, 2019
End Date
December 31, 2023
Last Updated
10 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Holger Cramer

Professor

Universität Duisburg-Essen

Eligibility Criteria

Inclusion Criteria

  • Patients with psoriasis having age 18 years or more
  • Patients with moderate-to-severe plaque psoriasis with a PASI score of 12 or higher
  • Psoriasis diagnosed 6 months or more before study entry
  • Those who are poorly controlled based on physicians assessment with topical treatments, phototherapy, systemic therapy, or a combination of these therapies.
  • Participants who have given informed consent.

Exclusion Criteria

  • Participants with other systemic illnesses
  • Lactating and pregnant mothers.
  • Alcohol dependence/Narcotic dependence /Steroid dependence
  • In the judgment of the investigator, unable or unwilling to follow the protocol and instructions

Arms & Interventions

Internal ayurvedic treatment

All possible internal preparations will be administered for a period of 12 months. All administered preparations with its dosage and duration will be documented All preparations will be subjected to lab test for clearing heavy metal and pesticide content before the administration

Intervention: Individualized internal ayurvedic treatment

External ayurvedic treatment

Application of warm external oil (Ayyapala kera tailam) on affected parts twice daily

Intervention: External ayurvedic treatment

Outcomes

Primary Outcomes

Psoriasis-specific quality of life

Time Frame: 6 months

Psoriasis specific DLQI scores

Secondary Outcomes

  • Psoriasis Severity(12 months)
  • Adverse events(12 months)
  • Psoriasis-specific quality of life(12 months)

Study Sites (1)

Loading locations...

Similar Trials